Should patient-reported outcomes be mandatory for toxicity reporting in cancer clinical trials?
Deborah Watkins
DW
Bruner
D016907:Adverse Drug Reaction Reporting Systems; D000970:Antineoplastic Agents / Q000009:adverse effects; D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D009862:Online Systems; D017063:Outcome Assessment, Health Care; D017060:Patient Satisfaction
D000970:Antineoplastic Agents